Brief: Heron Therapeutics Announces Results For Three Months Ended December 31, 2022

Heron Therapeutics

23/03/2023 20:08

March 23 (Reuters) - Heron Therapeutics Inc  HRTX.O :
    * HERON THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE
THREE AND
TWELVE MONTHS ENDED DECEMBER 31, 2022 AND HIGHLIGHTS RECENT
CORPORATE UPDATES
    * NET PRODUCT SALES FOR THREE AND TWELVE MONTHS ENDED
DECEMBER 31,
2022 WERE $30.0 MILLION AND $107.7 MILLION, RESPECTIVELY
    * NET LOSS FOR THREE MONTHS ENDED DECEMBER 31, 2022 WAS
$19.9
MILLION, OR $0.17 PER SHARE
    * Q4 EARNINGS PER SHARE VIEW $-0.29, REVENUE VIEW $26.9
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nPnbrW5W1a 
Further company coverage:  HRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))